Hematol Oncol Clin North Am
Bone NeoplasmsDesmoplastic Small Round Cell TumorOncogene Proteins, Fusion
Dr. Jonathan Metts, MD
NPI1831325646PAC ID7214227800
- Part D claims, 2024
- 26
- Publications
- 33
- Clinical trials
- 13
- MIPS score, 2024
- 88
- Hospital affiliations
- 1
- Practice address
- 10901 McKinley Dr, Tampa, FL 33612
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
H Lee Moffitt Cancer Center & Research Institute I - HOPD
Acute Care Hospital outpatient department · Tampa, Florida
Find Dr. Metts' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jonathan Metts is a pediatric hematology and oncology physician in Tampa, Florida
Dr. Metts practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.
Dr. Metts' NPI, 1831325646, was assigned on June 8, 2009. Dr. Metts graduated from School of Medicine Columbia in 2009. Dr. Metts holds Florida license ME129480.
NPI and contact details
- NPI
- 1831325646NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7214227800
- NPI enumeration date
- June 8, 2009
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 37
- Medical school graduation
- 2009
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Jonathan Metts practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida
Dr. Metts' primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.
- H Lee Moffitt Cancer Center & Research Institute I - HOPD10901 McKinley Dr, Tampa, FL 33612
Source: Dmand AI Affiliation Data
Dr. Jonathan Metts is affiliated with 4 sites of care and 2 medical groups
Dr. Metts' primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dr. Metts is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Metts to 2 more group practices and clinics and 1 medical group, each named with a free account.
H Lee Moffitt Cancer Center & Research Institute I - HOPDPrimary
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Jonathan Metts' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Metts practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| H Lee Moffitt Cancer Center & Research Institute I - HOPD | Available with a free account |
| +3 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Metts practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jonathan Metts is one of 152 pediatric hematologys and oncology physicians in Florida
Pediatric hematology-oncology is Dr. Metts' primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Metts is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Metts' licenses on file in 2 states: Florida and Georgia.
Specialties and state licenses
- Pediatric hematology and oncology, FloridaPrimary
- Georgia license
Pediatric hematologys and oncology physicians near Dr. Metts
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
152pediatric hematologys and oncology physicians in Florida18pediatric hematologys and oncology physicians in Tampa
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jonathan Metts' patients have a median age of 33
Across all payers, Dmand AI patient panel data puts Dr. Metts' median patient age at 33, with 49% women.
Dr. Metts' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 33
Patient panel by sex, all payers
- Women49%
- Men49%
Source: Dmand AI Patient Panel Data
Dr. Jonathan Metts wrote 26 Medicare Part D claims in 2024
In 2024, Dr. Metts wrote 26 Medicare Part D claims. 46% of them were for generic drugs.
Part D claims, 202426
Dr. Metts' Part D claims by kind of drug, 2024
- Generic12 claims46%
- Brand-name14 claims54%
Source: Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Jonathan Metts scored 88 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Metts for performance year 2024, reported as part of a group. Dr. Metts accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Metts as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Metts' MIPS scores, performance year 2024
- 88of 100Final score
- 74of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 71of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find pediatric hematologys and oncology physicians like Dr. Metts by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Jonathan Metts has 33 publications on record
Dmand AI links 33 papers to Dr. Metts, published from 2017 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Bone Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Osteosarcoma. Dr. Metts has published most often in Pediatr Blood Cancer. Dr. Metts' most frequent co-authors are Damon R. Reed, MD, Matteo Trucco, MD and Michael S. Isakoff, MD.
Papers33
Years published2017 to 2025
Dr. Metts' papers by year, 2017 to 2025
Topics Dr. Metts writes about most
- Bone Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- Osteosarcoma
- Sarcoma
- Rhabdomyosarcoma
- Albumins
- Biomarkers, Tumor
- Camptothecin
Dr. Metts' most frequent co-authors
- Damon R. Reed, MD5 shared papers
- Matteo Trucco, MD5 shared papers
- Michael S. Isakoff, MD3 shared papers
Recent publications by Dr. Metts
ConsensusEuropeLymphatic Metastasis
Immunotherapy, AdoptiveInterleukin-2Lymphocytes, Tumor-Infiltrating
Pediatr Blood Cancer
MastoidPyridonesPyrimidinones
See who Dr. Metts researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Metts works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Jonathan Metts has worked on 13 clinical trials
Dmand AI links Dr. Metts to 13 clinical trials, 7 of them phase 3 studies. 11 are still active or recruiting. Conditions studied include Osteosarcoma, Hepatoblastoma and Neuroblastoma. Children's Oncology Group sponsors the most, 7.
Clinical trials with Dr. Metts by phase
- 1Phase 1: 1 trial
- 1Phase 1/2: 1 trial
- 4Phase 2: 4 trials
- 7Phase 3: 7 trials
- NonePhase 4: no trials
Conditions in Dr. Metts' trials
- Osteosarcoma
- Hepatoblastoma
- Neuroblastoma
- Wilms Tumor
- Neoplasms, Bone Tissue
Investigators on the most trials with Dr. Metts
- Matthew Steven Dietz, DO6 shared trials
- Ramamoorthy Nagasubramanian, MD6 shared trials
- Wendy L. Woods-Swafford, MD6 shared trials
Recent clinical trials with Dr. Metts
A Phase 2 Study of DS-8201a (NSC# 807708) in Adolescents, or Young Adults With Recurrent HER2+ Osteosarcoma (opens in a new tab)
SuspendedPhase 2
OsteosarcomaNeoplasms, Bone TissueTrastuzumab Deruxtecan
Disease AttributesPathological Conditions, Signs and SymptomsGEM/DOX + TGFBi expanded NK cells
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma (opens in a new tab)
RecruitingPhase 3
OsteosarcomaNeoplasms, Bone Tissue
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT (opens in a new tab)
RecruitingPhase 2
Wilms TumorNeoplasms, Complex and MixedCarboplatinCyclophosphamideDoxorubicin
A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery (opens in a new tab)
Active, not recruitingPhase 2
Desmoid TumorsFibromaNirogacestat
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Jonathan Metts received $198 in industry payments from 2023 to 2025
CMS Open Payments shows 3 general payments to Dr. Metts from 2 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Ethicon Inc. paid the most, $126.
General payments to Dr. Metts by program year, 2023 to 2025
Companies that paid Dr. Metts the most, 2023 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Jonathan Metts graduated from School of Medicine Columbia
Dr. Metts graduated from School of Medicine Columbia in 2009.
- Medical school
- Board certified in pediatric hematology-oncology
Source: Dmand AI Professional Profile Data
Dr. Jonathan Metts accepts plans from 10 insurance carriers
Dr. Metts is in network with 10 carriers, including Aetna, Elevance and United Healthcare. POS plans come from the most carriers, 5. Check the plan with the practice before a visit.
- Aetna
- Elevance
- United Healthcare
- Blue Cross Blue Shield of Michigan
- Molina
- Aspirus Health Plan
- Blue Cross and Blue Shield of Kansas City
- CMS Medicare
- +2 more carriersWith a free account
Plan types Dr. Metts accepts, by number of carriers
- POS5
- PPO5
- HMO4
- Medicare4
- EPO3
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Jonathan Metts's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jonathan Metts
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jonathan Metts' NPI number?
Dr. Jonathan Metts' NPI number is 1831325646. It was assigned on June 8, 2009, and it is active in the NPI Registry.
What kind of doctor is Dr. Jonathan Metts?
Dr. Jonathan Metts is a pediatric hematology and oncology physician in Tampa, Florida. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Jonathan Metts practice?
Dr. Metts practices at 10901 McKinley Dr, Tampa, FL 33612. Dr. Metts' primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dmand AI also links Dr. Metts to 2 group practices and clinics and 1 medical group.
What is Dr. Jonathan Metts' medical license number?
Dr. Metts holds Florida license ME129480, one of the licenses on file in 2 states.
Which states has Dr. Jonathan Metts been licensed in?
Dmand AI has state licenses on file for Dr. Metts in Florida (2016 to 2027) and Georgia (2013 to 2016).
Which hospitals is Dr. Jonathan Metts affiliated with?
Dr. Metts is affiliated with Moffitt Cancer Hospital.
What medical group is Dr. Jonathan Metts part of?
Dr. Metts is linked to Moffitt Cancer Center. Dmand AI links Dr. Metts to 1 more medical group.
Does Dr. Jonathan Metts accept Medicare?
Yes. CMS lists Dr. Metts as accepting Medicare assignment.
Does Dr. Jonathan Metts offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Metts as offering telehealth services.
What is Dr. Jonathan Metts' MIPS score?
Dr. Metts' MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.
Show 7 more questionsShow fewer questions
Is Dr. Jonathan Metts board certified?
Yes. Dr. Metts is board certified in pediatric hematology-oncology by the American Board of Pediatrics.
Where did Dr. Jonathan Metts go to medical school?
Dr. Metts graduated from School of Medicine Columbia in 2009.
Has Dr. Jonathan Metts received payments from drug or device companies?
CMS Open Payments shows $198 in general payments to Dr. Metts from 2 companies from 2023 to 2025. The largest total came from Ethicon Inc.
How long has Dr. Jonathan Metts been practicing?
Dr. Metts graduated from medical school in 2009, 17 years ago.
Does Dr. Jonathan Metts do research?
Dmand AI links 33 publications to Dr. Metts, published from 2017 to 2025. Dr. Metts has worked on 13 clinical trials.
Who does Dr. Jonathan Metts publish with?
Dr. Metts' most frequent co-authors are Damon R. Reed, MD (5 shared papers), Matteo Trucco, MD (5 shared papers) and Michael S. Isakoff, MD (3 shared papers).
What insurance does Dr. Jonathan Metts accept?
Dr. Metts is in network with 10 carriers, including Aetna, Elevance and United Healthcare. POS plans come from the most carriers, 5. Check the plan with the practice before a visit.
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card